World Ion Channel Modulating Drugs Market Canvassed in Topical Global Industry Analysts Study Published at …

Posted: Published on May 24th, 2013

This post was added by Dr P. Richardson

LONDON--(BUSINESS WIRE)--

The global ion channel modulators market is forecast to reach a value of USD21.4bn by end-2018, driven largely by deeper understanding of channelopathies and ongoing advances in electrophysiology, particularly automated electrophysiology.

Globally, the United States represents the largest market for ion channel modulating drugs, with Europe coming after. Today, around 14% of the commercial drugs in the global pharma business are based upon ion channel modulation. With developments in ion channel screening technology, more drugs are expected to be produced on a commercial scale in the closest run. Presently, a good many global companies, from pharma giants like GlaxoSmithKline and Pfizer to medium and small-sized biotech firms, are making huge investments into ion channel research and drug development.

Topical research study Ion Channel Modulators: Market Research Report created by Global Industry Analysts provides in-depth coverage of the ion channel modulators market on a global scale, along with delivering separate comprehensive analytics for the United States, Canada, Japan, Europe, the Asia-Pacific, Latin America, and RoW. It contains annual estimates and forecasts for the 2010-2018 period; besides including a six-year historic analysis for these markets.

Furthermore, the report analyzes the competitive landscape and profiles 48 companies including many key and niche players, such as AstraZeneca, Aurora Biomed, Inc., CalciMedica, Inc., Cellectricon AB, Convergence Pharmaceuticals Limited, Cytocentrics AG, Evotec AG, flyion GmbH, GlaxoSmithKline Plc, Neusentis, Inc., Nanion Technologies GmbH, NeuroSearch A/S, Novartis AG, Parion Sciences, Inc., Pfizer, Inc., Sanofi, Targacept, Inc., Xention Limited, and Zalicus, Inc. Microsoft Corporation, QNX Software Systems Ltd., Renesas Electronics Corporation, VIA Technologies, Inc., and Zilog, Inc.

Report Details:

Title: Ion Channel Modulators: Market Research Report

Published: March, 2013

Pages: 404

Price: US$ 4,500.00

More:
World Ion Channel Modulating Drugs Market Canvassed in Topical Global Industry Analysts Study Published at ...

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.